How much funding has Emocog raised?

Emocog has raised $15.0M in total funding, most recently a Series B round.

Who are Emocog's investors?

Emocog's investors include Stonebridge Capital, Envisioning Partners, Shinhan Venture Investment, KB Investment, Industrial Bank of Korea, Kakao Investment.

Where is Emocog headquartered?

Emocog is headquartered in Seoul, South Korea.

What industry is Emocog in?

Emocog operates in Artificial Intelligence, Healthcare.

Emocog

Digital therapeutics for cognitive health

Seoul, South Korea · Founded 2021 · $15.0M raised

Artificial Intelligence

Healthcare

Headquarters: Seoul
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: emocog.com
Total Funding: $15.0M
Last Round: $15.0M Series BDec 2024
Rounds: 2

About

Emocog is a Seoul-based digital therapeutics company developing Software as a Medical Device (SaMD) for cognitive health. The company's flagship products include Cogthera (Korea's first prescription digital therapeutic for mild cognitive impairment), Cogscreen (a digital cognitive assessment tool), and Cogcheck (an integrated clinician platform for cognitive care). Emocog raised 15 billion KRW in a Pre-A round and has partnerships with global companies including EISAI and Quanterix, backed by investors such as Kakao, Naver, and Stonebridge.

Summary

Emocog is an Artificial Intelligence company based in Seoul, South Korea, founded in 2021. It has raised $15.0M in total across 2 rounds, most recently a $15.0M Series B round in Dec 2024. Investors include Stonebridge Capital, Envisioning Partners and Shinhan Venture Investment.